Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.